Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS)

Historical Holders from Q3 2024 to Q3 2025

Symbol
ALGS on Nasdaq
Type / Class
Equity / Voting Common Stock, par value $0.0001 per share
Shares outstanding
5.38M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2.65M
Holdings value
$26M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
33
Number of buys
16
Number of sells
-14
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Alyeska Investment Group, L.P. 9.99% $2.81M 530K Alyeska Investment Group, L.P. 31 Mar 2025
Woodline Partners LP 8.7% -11% $4.59M -$491K 468K -9.67% Woodline Partners LP 30 Sep 2025
Sio Capital Management, LLC 5.49% $2.57M 356K Sio Capital Management, LLC 30 Jun 2025
EcoR1 Capital, LLC 3.9% $1.12M 211K EcoR1 Capital, LLC 31 Mar 2025
Adage Capital Management, L.P. 3.9% -60.9% $1.51M -$829K 210K -35.4% Adage Capital Management, L.P. 30 Jun 2025
ARMISTICE CAPITAL, LLC 4.99% $999K 188K Armistice Capital, LLC 31 Dec 2024
BLATT LAWRENCE 3.2% $930K 176K Lawrence M. Blatt, Ph.D. 10 Mar 2025

Institutional Holders of Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2.65M $26M +$21.3K $9.80 33
2025 Q2 2.71M $19.5M -$4.85M $7.21 37
2025 Q1 3.3M $27.1M +$7.68M $8.25 35
2024 Q4 1.62M $64.5M +$11.8M $39.84 33
2024 Q3 1.69M $14.7M +$14.6M $8.66 27